| Tap a line for its trend | Last 12Mto Jun 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 2,309.13× | 2,309.13× | 129.68× | 53.26× | 35.80× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 43,668.22× | 43,668.22× | 1,479.92× | 763.43× | 252.77× | ||
| 15,515.40× | 15,515.40× | 870.22× | 210.22× | 61.91× | ||
| 30,461.95× | 30,461.95× | 739.38× | 606.47× | 226.66× | ||
| 0.00× | −0.01× | −0.13× | −2.39× | 2.65× | ||
| 0.00× | 0.00× | 0.03× | 0.08× | 0.24× | ||
| −1.19× | −1.19× | 0.40× | 0.07× | 1.35× | ||
| 0.26× | 0.26× | 0.47× | 1.96× | −39.85× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/06/2026 | |
|---|---|---|---|---|---|---|
| Inventory Days (DIO) | 35.80 | 53.26 | 129.68 | 2,309.13 | 2,309.13 | |
| Receivable Days (DSO) | 252.77 | 763.43 | 1,479.92 | 43,668.22 | 43,668.22 | |
| Payable Days (DPO) | 61.91 | 210.22 | 870.22 | 15,515.40 | 15,515.40 | |
| Cash Conversion Cycle (days) | 226.66 | 606.47 | 739.38 | 30,461.95 | 30,461.95 | |
| Working Capital Turnover | 2.65 | -2.39 | -0.13 | -0.01 | -0.00 | |
| Asset Turnover | 0.24 | 0.08 | 0.03 | 0.00 | 0.00 | |
| Cash Conversion (CFO/Net Income) | 1.35 | 0.07 | 0.40 | -1.19 | -1.19 | |
| CFO/EBITDA | -39.85 | 1.96 | 0.47 | 0.26 | 0.26 |